CN120858103A - 环肽或其盐及它们的利用 - Google Patents

环肽或其盐及它们的利用

Info

Publication number
CN120858103A
CN120858103A CN202480017097.9A CN202480017097A CN120858103A CN 120858103 A CN120858103 A CN 120858103A CN 202480017097 A CN202480017097 A CN 202480017097A CN 120858103 A CN120858103 A CN 120858103A
Authority
CN
China
Prior art keywords
residue
seq
amino acid
cyclic peptide
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480017097.9A
Other languages
English (en)
Chinese (zh)
Inventor
泉田森
羽场亮太
富永让
石井由纪子
吉村直子
和田史织
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of CN120858103A publication Critical patent/CN120858103A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
CN202480017097.9A 2023-03-17 2024-03-15 环肽或其盐及它们的利用 Pending CN120858103A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2023-043076 2023-03-17
JP2023043076 2023-03-17
JP2023170565 2023-09-29
JP2023-170565 2023-09-29
PCT/JP2024/010163 WO2024195709A1 (ja) 2023-03-17 2024-03-15 環状ペプチド又はその塩及びそれらの利用

Publications (1)

Publication Number Publication Date
CN120858103A true CN120858103A (zh) 2025-10-28

Family

ID=92841650

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480017097.9A Pending CN120858103A (zh) 2023-03-17 2024-03-15 环肽或其盐及它们的利用

Country Status (5)

Country Link
US (1) US20260008818A1 (https=)
EP (1) EP4682157A1 (https=)
JP (1) JPWO2024195709A1 (https=)
CN (1) CN120858103A (https=)
WO (1) WO2024195709A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026071086A1 (ja) * 2024-09-27 2026-04-02 ペプチドリーム株式会社 ペプチド、ペプチド複合体、細胞培養用組成物、医療用、診断用又は研究用に用いられる組成物、及びペプチド複合体の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR50E (fr) 1901-07-17 1902-10-13 Roche Un nouveau procédé de dégrisage du velours
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
AU6309399A (en) 1998-05-28 2000-02-01 Chugai Pharmaceutical Co., Ltd. Peptide ligands for the human fibroblast growth factor (fgf) receptor
US6548634B1 (en) * 1998-09-30 2003-04-15 Chiron Corporation Synthetic peptides having FGF receptor affinity
JP4010163B2 (ja) 2002-03-18 2007-11-21 株式会社Ｉｈｉ 破砕機用刃物
ATE545655T1 (de) * 2004-06-18 2012-03-15 Enkam Pharmaceuticals As Fgfr-bindende peptide
JP2009511614A (ja) * 2005-10-19 2009-03-19 エンカム ファーマシューティカルズ アクティーゼルスカブ 繊維芽細胞成長因子受容体誘導ペプチド
US20090042802A1 (en) * 2007-06-22 2009-02-12 Yijun Pan Compounds and peptides that bind the kgf receptor
WO2009100724A1 (en) * 2008-02-11 2009-08-20 Kobenhavns Universitet Novel peptide derived from ncam (bcl)
EP3366693B1 (en) 2015-10-23 2023-08-16 FUJIFILM Corporation Cyclic peptide, affinity chromatography support, labeled antibody, antibody-drug conjugate, and pharmaceutical preparation
JP2021070652A (ja) 2019-10-31 2021-05-06 味の素株式会社 線維芽細胞増殖因子受容体１結合ペプチド
WO2022115778A1 (en) * 2020-11-30 2022-06-02 Rayzebio, Inc. Radiopharmaceutical conjugate compositions and uses thereof

Also Published As

Publication number Publication date
WO2024195709A1 (ja) 2024-09-26
JPWO2024195709A1 (https=) 2024-09-26
US20260008818A1 (en) 2026-01-08
EP4682157A1 (en) 2026-01-21

Similar Documents

Publication Publication Date Title
JP7417432B2 (ja) 新規リンカー、その製造方法およびその応用
EP2141175B1 (en) Process for synthesizing cyclic peptide compound
JP4972191B2 (ja) ペプチド、蛋白質及びペプチドミメティック合成のための方法及び組成物
US20260008818A1 (en) Cyclic peptide or salt thereof, and uses thereof
EP4071178A1 (en) Method for producing peptide having physiological activity, and peptide comprising short linker
CN101443351A (zh) 修饰的促进血细胞生成的分子
EP4410982A1 (en) Method for producing polypeptide, tag, expression vector, method for evaluating polypeptide, method for producing nucleic acid display library, and screening method
US7091313B2 (en) Synthesis of template-fixed β-hairpin loop mimetics
JP2004531225A5 (https=)
Nakamura et al. Synthesis of peptide thioesters via an N–S acyl shift reaction under mild acidic conditions on an N‐4, 5‐dimethoxy‐2‐mercaptobenzyl auxiliary group
US20220098240A1 (en) Cyclic peptide, cell scaffold material, cell separating material, and medium
CN120858104A (zh) 环肽或其盐及它们的利用
CN120826410A (zh) 环肽或其盐及它们的利用
US9783800B2 (en) Method for producing peptides having azole-derived skeleton
EP4063377A1 (en) Modification of trna t-stem for enhancing n-methyl amino acid incorporation
Ferrer‐Gago et al. Synthesis of C‐terminal glycine‐rich o‐aminoanilide peptides without overacylation for use in benzotriazole‐mediated native chemical ligation
AU768443B2 (en) Method for stabilising proteins in complex mixtures during their storage in aqueous solvents
JPWO2019239751A1 (ja) 細胞移植用組成物及び細胞移植方法
CN120936617A (zh) 制备生理活性评价用多肽溶液的方法及评价多肽的生理活性的方法
EP4675020A1 (en) Method for producing nucleic acid display library, screening method, and method for producing polypeptides
CN119403820A (zh) 肽以及含肽剂
崔岩 et al. Development of 4-fluorophenyl 3-nitro-2-pyridinesulfenate as a new Npys protecting reagent and its application to efficient disulfide formation
JP2009029794A (ja) ケージド化合物の製造方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination